Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients

Journal of Viral Hepatitis

Volumn 9, Issue 3, 2002, Pages 194-201

  Hino, Keisuke ^a   Korenaga, M ^a   Orito, E ^b   Katoh, Y ^a   Yamaguchi, Y ^a   Ren, F ^a   Kitase, A ^a   Satoh, Y ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Hepatitis C virus; Hypervariable region; Interferon; Secondary structure

Indexed keywords

INTERFERON; PROTEIN HYPERVARIABLE REGION 1; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; VARIATION (GENETICS); VIRAL PROTEINS;

EID: 0036906969     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00349.x     Document Type: Article

References (22)

1. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-228.
2. Weiner AJ, Brauer MJ, Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-848.
3. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infection. Proc Natl Acad Sci USA 1992; 89: 3468-3472.
4. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol 1997; 71: 4123-4127.
5. Higashi Y, Kakumu S, Yoshioka K et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659-668.
6. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 1494-1500.
7. Kato N, Ootsuyama Y, Sekiya H et al. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 4776-4784.
8. McAllister J, Casino C, Davidson F et al. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998; 72: 4893-4905.
9. Korenaga M, Hino K, Katoh Y et al. A possible role of hypervariable region 1 in escape of hepatitis C virus particles from neutralization. J Viral Hepat 2001; 8: 331-340.
10. Fujii K, Hino K, Okazaki M et al. Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Biochem Biophys Res Commun 1996; 225: 771-776.
11. Korenaga M, Hino K, Okazaki M, Okuda M, Okita K. Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles. Biochem Biophys Res Commun 1997; 240: 677-682.
12. Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 1978; 120: 97-120.
13. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K. Genetic alternations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1. Int J Cancer 1994; 57: 664-670.
14. Sherman KE, Andreatta C, Obreien J, Gutierrez A, Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain. Hepatology 1996; 23: 688-694.
15. Pawlotsky JP, Germanidis G, Frainais PO et al. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999; 73: 6490-6499.
16. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hyper-variable region 1 points to a role in cell attachment. J Virol 2001; 75: 5703-5710.
17. Puntoriero G, Meola A, Lahm A et al. Towards a solution for hepatitis C virus hypervariability: Mimotopes of the hyper-variable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 1998; 17: 3521-3533.
18. Taniguchi S, Okamoto H, Sakamoto M et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology 1993; 195: 297-301.
19. Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J Virol 1999; 73: 2938-2946.
20. Mondelli MU, Cerino A, Lisa A et al. Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation. Hepatology 1999; 30: 537-545.
21. Smith DB. Evolution of the hypervariable region of hepatitis C virus. J Viral Hepat 1999; 6 (Suppl. 1): 41-46.
22. Yamaguchi Y, Gojobori T. Evolutionary mechanism and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA 1997; 94: 1264-1269.